Close
Close
Treatment Database
N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide
Trade Name not avaiable
Orphan Indication Peripheral T-cell lymphoma
EU Market Approval
EU Designation Date 08-11-2017
Sponsor Celleron Therapeutics Limited
More about T-cell lymphoma
Free Newsletter
Related Videos
by Abidemi Uruejoma
6,893 views